NCT07565051

Brief Summary

The goal of this observational study is to evaluate whether preoperative fat-free mass predicts post-operative weight loss in patients undergoing Roux-En-Y gastric bypass. The primary objective of this study is to evaluate whether preoperative fat-free mass predicts weight loss in the two years following RYGB. We will collect the following data, assessed as part of routine follow-up:

  • height, weight, hip and waist circumferences
  • body composition by bioimpedance analysis and dual energy-X-ray absorptiometry
  • Muscle strength and physical activity
  • Nutritional parameters: resting energy expenditure, eating behavior and digestive tolerance", plasma micronutrient status. .
  • Cardiovascular risk factors: fasting glucose, blood levels of Hb1Ac, triglycerides, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, blood pressure
  • Co-morbidities: joint pain and arthritis, sleep apnea, gastro-oesophageal reflux, metabolic dysfunction-associated fatty liver disease (MAFLD), cancer, stroke, heart attack. Quality of life: quality of life by the "Bariatric Analysis and Reporting Outcome (BAROS) questionnaire", symptoms of dumping syndrome by the "Sigstad diagnostic score system" Birthdate, birthweight and term of their children

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
91

participants targeted

Target at P50-P75 for all trials

Timeline
76mo left

Started Aug 2025

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress10%
Aug 2025Aug 2032

Study Start

First participant enrolled

August 18, 2025

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

April 27, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 4, 2026

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 18, 2027

Expected
5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 18, 2032

Last Updated

May 4, 2026

Status Verified

April 1, 2026

Enrollment Period

2 years

First QC Date

April 27, 2026

Last Update Submit

April 27, 2026

Conditions

Keywords

obesitygastric bypassbody compositionbone mineral densityhandgrip strengthsarcopenic obesity

Outcome Measures

Primary Outcomes (2)

  • Correlation between Fat-free mass (FFM) and weight loss following RYGB

    FFM and lean body mass measurement using BIA and DXA, respectively

    2 years

  • Evolution of body composition in the two years after bariatric surgery

    Measurments of body composition by dual energy X-ray absorptiometry before gastric bypass and yearly after gastric bypass

    5 years

Study Arms (1)

Patients with scheduled RYGB at the Geneva University Hospitals

Morbidly obese patients scheduled for Roux-en-Y gastric bypass

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with scheduled gastric bypass at the Geneva University Hospitals (HUG)

You may qualify if:

  • Patients ≥ 18 years AND
  • Scheduled RYGB at the HUG OR previous RYGB at the HUG with a present follow-up in Clinical Nutrition and dietetics at the HUG AND
  • Understanding French

You may not qualify if:

  • Inability or refusal to give consent.
  • Planification for another type of bariatric surgery than RYGB
  • Contra-indications to bariatric surgery as stated under www.smob.ch: insufficient nutritional knowledge in nutrition to lose weight, pregnancy, kidney failure (Creatinine ≥ 300 umol/l without dialysis, Crohn's disease, active cancer or remission \< 2 years, active psychiatric disease, substance abuse (alcohol, cannabis, opioids), absence of compliance, lack of understanding of the requirements and necessary lifestyle changes reported by physician or dietician.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Geneva University Hospitals

Geneva, Canton of Geneva, 1205, Switzerland

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

Blood biobank and gastric and intestinal tissue biobank

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Laurence Genton, MD

CONTACT

Laure Wilmart-Beck

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 27, 2026

First Posted

May 4, 2026

Study Start

August 18, 2025

Primary Completion (Estimated)

August 18, 2027

Study Completion (Estimated)

August 18, 2032

Last Updated

May 4, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations